Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Tln Q4 Earnings Beats Estimates By 1.17 20260403 Is Or Or Stock In A Downtrend Price At 40.27 Up 0.40 20260402 How Does Macroeconomics Affect Yd Bio Ydes Stock Price At 5.97 Down 4.57 20260413 What Is The Future Of T Mobile Tmusz Stock Price At 21.76 Up 0.51 20260413 Why Is Blackstone Mtg Bxmt Stock Outperforming Recently Bxmt Q4 Earnings Misses Estimates By 2.34 20260413 1 UWM UWMC reports Q4 EPS miss 008 misses estimate by 93 shares unchanged HBANP Huntington Bancshares Series H Preferred Stock posts narrow Q4 2025 EPS miss shares edge higher in todays trading How General GAM guidance shapes future expectations GAM Q4 Earnings Portfolio Shifts in Focus as General Navigates Market Conditions When is WhiteHorse WHFCL next earnings date and what matters most Q1 2026 Earnings Fall Short ISBA Isabella posts steep Q4 2025 earnings miss pushing shares down 527 percent even as revenue rises 115 percent Adobe Inc ADBE Agentic AI Suite Launch and 25 Billion Share Repurchase Program Reshape Investment Thesis THG Hanover posts narrow Q2 2000 earnings beat and 56 percent revenue growth shares drop 1 percent NEWTI NewtekOne reports Q4 2025 EPS below consensus estimates as shares remain unchanged in daily trading Fenbo FEBO Stock VWAP Break Weakens 20260420 The RD spending story behind The RealReal REAL innovation The RealReal Beats EPS Forecast Loss Narrows What Form 4 filings Affiliated MGRB Buying Pressure 20260427 US Private Sector Retirement Savings Policy Proposal How James JHX translates market opportunities into growth 136 20260505 DuPont de Nemours Inc DD Launches AIPowered Reverse Osmosis Operations Advisor to Expand Water Solutions Digital Portfolio Rising Geopolitical Tensions Drive 40bn Surge in US Fuel Costs Western MHF Trading at 699 Key Decision Point 20260515 NFL Seeks Ban on First Play and InjuryRelated Prediction Market Contracts Calls for Higher Age Limits Heron Therapeutics HRTX Q1 2026 Disappoints EPS 004 Below 002 Views Syndax Pharmaceuticals SNDX Drops 161 Key Support at 1921 20260515 Crane NXT CXT Slips 140 Testing 3591 Support 20260519 Uranium Royalty UROY Q1 2026 Beat Revenue NA EPS Exceeds by Significant Fortress FVAV at 1010 Buy Sell or Hold 20260519 Skilled Trade Pay Surge Challenges College Career Path Recruitment Giant Says MGM MGM Sheds 119 Support at 3429 Now Critical 20260521 JewettCameron JCTC Declines 400 Amid Market Weakness 20260520 AI Frenzy Drives Over 100 Gains for Select European Stocks This Year Pine Labs Reports Turnaround Rs 59 Crore Net Profit in Q4 on 17 Revenue Growth Indias Labor Market Under Pressure as Iran Conflict Disrupts Remittances and Trade Tokyo Governor Pushes Hydrogen and AI Collaboration as Model for Resilient Urban Economies ixigo Partners with Uber and redBus to Enhance Train Travel Experience with Integrated Cab and Bus Bookings Eli Lilly Expands Vaccine Portfolio with Acquisition of Three Developers Whirlpool Q1 2026 Earnings A Major EPS Miss Amid Weak Appliance Demand DuPont Q1 2026 Earnings EPS Surprise Lifts Shares ThredUp Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Stock MESO Q1 2026 Earnings Slightly Wider Loss in PreRevenue Quarter Stock Advances PowerFleet Inc AIOT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable AOD Holds Near 1041 as Support and Resistance Levels Tighten Life Time Group Holdings LTH Falters Analyzing Support Levels After a 267 Decline FACTU Holds Steady at 1145 Amid Flat Trading Key Levels to Watch Nautilus Biotechnology NAUT Holds Steady at 254 as Stock Consolidates Near Key Levels Ethos Technologies LIFE Q1 2026 Earnings EPS Surges Past Expectations Driving Stock Higher US Global Investors Inc GROW Q1 2026 Earnings Strong EPS Amid Missing Revenue Disclosure Mercurys 52 Billion Valuation Marks 49 Surge Reinforcing Fintech Resilience Hennessy Advisors Inc HNNA Q1 2026 Earnings EPS of 024 Amid Flat Revenue and Negative Market Reaction REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Awaits Clinical Milestones